how long have glp-1 drugs been on the market 🔮 GLP-1s could transform society GLP-1 Receptor Agonist Market Size

Rytelo is specifically approved for MDS patients with transfusion-dependent anemia who do not respond to or are ineligible for the standard-of-care treatment, erythropoiesis-stimulating agents

Nehlig A

Benefits Beyond Weight Loss While the primary benefit of GLP-1/GIP receptor agonists is weight loss, these medications offer several other significant health advantages: Improved Glycemic Control : By regulating blood sugar levels, GLP-1/GIP receptor agonists can help prevent the complications associated with diabetes, such as neuropathy, retinopathy, and cardiovascular diseases

Takahashi K, Yamanaka S

Lifestyle Factors Associated with Abdominal Pain in Quiescent Inflammatory Bowel Disease